枸橼酸西地那非治疗肺动脉高压 - Suppr

Suppr

超能文献

Sildenafil citrate therapy for pulmonary arterial hypertension.

作者信息

Hoeper Marius M, Welte Tobias

出版信息

N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3. doi: 10.1056/NEJMc053442.

DOI:10.1056/NEJMc053442

PMID:16525151

Abstract

摘要

相似文献

Sildenafil citrate therapy for pulmonary arterial hypertension.

N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3. doi: 10.1056/NEJMc053442.

Sildenafil citrate therapy for pulmonary arterial hypertension.

N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3.

Sildenafil citrate therapy for pulmonary arterial hypertension.

N Engl J Med. 2006 Mar 9;354(10):1091-3; author reply 1091-3.

Summary for patients. Sildenafil (Viagra) may help improve control of pulmonary hypertension.

Ann Intern Med. 2002 Apr 2;136(7):I35. doi: 10.7326/0003-4819-136-7-200204020-00003.

Sildenafil in pulmonary hypertension.

Indian Heart J. 2003 May-Jun;55(3):285; author reply 285.

Sildenafil in primary pulmonary hypertension.

N Engl J Med. 2000 Nov 2;343(18):1342. doi: 10.1056/NEJM200011023431814.

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

Ann Intern Med. 2002 Apr 2;136(7):515-22. doi: 10.7326/0003-4819-136-7-200204020-00008.

[Treatment of pulmonary arterial hypertension: phosphodiesterase-5 inhibitors].

Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S311-4. doi: 10.1055/s-2006-957199.

Sildenafil citrate therapy for pulmonary arterial hypertension.

N Engl J Med. 2005 Nov 17;353(20):2148-57. doi: 10.1056/NEJMoa050010.

Central retinal vein occlusion in a patient after being commenced on sildenafil citrate for pulmonary arterial hypertension.

Indian J Chest Dis Allied Sci. 2009 Oct-Dec;51(4):249-51.

引用本文的文献

Int J Mol Sci. 2023 Jan 25;24(3):2391. doi: 10.3390/ijms24032391.

Pathogenic Mechanisms of Pulmonary Arterial Hypertension: Homeostasis Imbalance of Endothelium-Derived Relaxing and Contracting Factors.

JACC Asia. 2022 Dec 15;2(7):787-802. doi: 10.1016/j.jacasi.2022.09.010. eCollection 2022 Dec.

Idiopathic pulmonary fibrosis and pulmonary hypertension: Heracles meets the Hydra.

Br J Pharmacol. 2021 Jan;178(1):172-186. doi: 10.1111/bph.15036. Epub 2020 Apr 7.

Effect of a phosphodiesterase-5A (PDE5A) gene polymorphism on response to sildenafil therapy in canine pulmonary hypertension.

Sci Rep. 2019 May 3;9(1):6899. doi: 10.1038/s41598-019-43318-z.

Selective serotonin reuptake inhibitors and cardiovascular events: A systematic review.

J Res Med Sci. 2016 Sep 1;21:66. doi: 10.4103/1735-1995.189647. eCollection 2016.

Cardiac manifestations in systemic sclerosis.

World J Cardiol. 2014 Sep 26;6(9):993-1005. doi: 10.4330/wjc.v6.i9.993.

Pulmonary hypertension-"state of the art" management in 2012.

Indian Heart J. 2012 Jan-Feb;64(1):60-73. doi: 10.1016/S0019-4832(12)60013-3. Epub 2012 Mar 26.

The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension.

Vasc Health Risk Manag. 2010 May 6;6:273-80. doi: 10.2147/vhrm.s6392.

Sildenafil in the treatment of pulmonary hypertension.

Vasc Health Risk Manag. 2006;2(4):411-22. doi: 10.2147/vhrm.2006.2.4.411.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验